|
Corporate Overview
CEL-SCI Corporation (AMEX: CVM), a biotechnology company, was formed in 1983. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The Company's core capabilities include: drug discovery, research, development and manufacturing of complex biological substances.
| CORPORATE OFFICERS |
|
| |
|
|
Maximilian de Clara
Director and President
Geert R. Kersten
Director and Chief Executive Officer
Patricia B. Prichep
Senior Vice President of Operations
Secretary
Eyal Talor, Ph.D.
Chief Scientific Officer
Daniel Zimmerman, Ph.D.
Senior Vice President of Research,
Cellular Immunology
John Cipriano
Senior Vice President of Regulatory Affairs
|
|
| |
|
CORPORATE HEADQUARTERS |
|
| |
|
CEL-SCI Corporation
8229 Boone Boulevard, Suite 802
Vienna, VA 22182 USA
Telephone (703) 506-9460
Facsimile (703) 506-9471
If you would like to share your feedback with us via e-mail, we invite you to send us your comments or letters to
Feedback@cel-sci.com. |
|
| |
|
BOARD OF DIRECTORS |
|
| |
|
|
Maximilian de Clara
Chairman and President
CEL-SCI Corporation
Geert R. Kersten
Chief Executive Officer
CEL-SCI Corporation
Alexander G. Esterhazy
Financial Advisor
C. Richard Kinsolving, Ph.D.
Chief Executive Officer
BioPharmacon, Inc.
Peter Young, Ph.D.
Chief Executive Officer
Agnus Dei, LLC |
|
| |
| |
| CERTIFIED PUBLIC ACCOUNTANTS |
|
| |
|
|
BDO USA, LLP
Bethesda, MD |
|
| |
|
COUNSEL |
|
| |
|
Hart & Trinen
Denver, CO |
|
| |
|
TRANSFER AGENT AND REGISTRAR |
|
| |
|
|
Computershare Investor Services
350 Indiana Street, Suite 800
Golden, CO 80401
(303) 262-0600 |
|
| |
|
STOCKHOLDERS INQUIRIES |
|
| |
|
| Inquiries regarding transfer requirements, lost certificates and change of address should be directed to the transfer agent. |
|
| |
|
STOCK PROFILE |
|
| |
|
CEL-SCI Corporation's Common Stock is traded on the American Stock Exchange under the symbols CVM. CEL-SCI also trades on the German Stock Exchanges under the symbol LSR, German Securities Code (Wertpapierkennnummer) 871006.
There are approximately 1,800 stockholders of record as of September 30, 2009. The Company has not paid cash dividends on its Common Stock since its inception. |
|
| |
|
SEC FORM 10-K |
|
| |
|
A copy of the Company's annual report to the Securities and Exchange Commission on Form 10-K is available without charge upon written request to:
Corporate Communications
CEL-SCI Corporation
8229 Boone Boulevard, Suite 802
Vienna, VA 22182 USA |
|
| |
|
|
COMPANY CODE OF ETHICS
|
|
| |
|
|
|
| |
| |
|
